Clinipace

Clinipace Worldwide co-founders named E&Y Entrepreneur of the Year finalists

Thursday, May 7, 2015 12:44 PM

Clinipace Worldwide, a global digital CRO, has announced Jeff Williams, CEO and co-founder, and Chris Porter, president and co-founder, have been named one of three finalists in the Health Care & Life Sciences category of the Ernst & Young Entrepreneur Of The Year 2015 Southeast Program, which includes Alabama, Georgia, North Carolina, South Carolina and Tennessee. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in areas such as innovation, financial performance and personal commitment to their businesses and communities.

More... »


Karyopharm Therapeutics enters agreement with Clinipace Worldwide

Thursday, April 10, 2014 01:49 PM

Clinipace Worldwide, a global digital CRO (dCRO), has announced that Karyopharm Therapeutics, a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology and wound healing.

More... »


Clinipace Worldwide expands into Asia with acquisition of Choice Pharma

Tuesday, March 11, 2014 09:12 AM

Clinipace Worldwide, a global digital CRO (dCRO), has merged with Choice Pharma, a Pan-Asian CRO.  

More... »

Clinipace, Medfiles partner

Monday, August 5, 2013 11:55 AM

Global CRO Clinipace Worldwide has partnered with Finland-based CRO Medfiles, which specializes in pharmaceutical development and analytical services, clinical trial support, health economics and regulatory affairs.

More... »

Clinipace Worldwide acquires Paragon Biomedical

Tuesday, September 25, 2012 07:00 AM

Clinipace Worldwide, a global digital contract research organization (dCRO), and Paragon Biomedical, a global, full-service CRO, have jointly announced a definitive merger agreement under which Morrisville, N.C.-based Clinipace Worldwide has acquired all outstanding shares of privately-held, Irvine, Calif.-based Paragon and its subsidiaries.

More... »

Clinipace Worldwide to manage Prometheus oncology program

Wednesday, July 18, 2012 01:29 PM

Morrisville, N.C.-based Clinipace Worldwide, a global digital research organization (dCRO), said Prometheus Laboratories, a specialty pharmaceutical and diagnostic company, has awarded it an Oncology Program.  Immediate plans are commencing for two metastatic melanoma studies.  

More... »

Clinipace names VP, European clinical operations

Wednesday, November 2, 2011 12:17 PM

Clinipace Worldwide has named Andrea Schiefer, Ph.D., vice president of European clinical operations and executive director of pharmacovigilance. In this position, Andrea reports directly to Kurt Pfister, chief executive officer of European operations at Clinipace Worldwide, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the European clinical operations unit at Clinipace Worldwide.

More... »

Larus joins Clinipace Worldwide

Tuesday, October 18, 2011 02:04 PM

Clinipace Worldwide has named John Larus executive vice president of clinical operations. In this newly created position, John reports directly to Chris Porter, chief operating officer, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the U.S. clinical operations unit.

More... »

Clinipace secures $15M in Series C financing

Tuesday, September 27, 2011 12:34 PM

Clinipace Worldwide has closed a $15M Series C round of funding led by Morgan Stanley Expansion Capital of San Francisco, CA.  Existing investors, including Hatteras Venture Partners of Durham, NC, and Brook Private Equity Advisors of Boston, MA, also participated in this most recent round of funding.

More... »

Clinipace acquires PFC Pharma Focus

Monday, May 23, 2011 08:47 AM

While industry news has been dominated by medium to large CRO acquisitions, consolidation is taking place in the smaller end of the market, too. Last Wednesday morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »


CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs